๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Non-Small Cell Lung Cancer
Clinical trial register · Sweden

Non-Small Cell Lung Cancer Trials in Sweden, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 2213 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:46 UTC
2213
Studies in scope
all four open statuses
1238
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 8 Gothenburg 5 Uppsala 3 Lund 3 Solna 2
Narrow the registerReset
Recruitment status
Phase
Site location
Stockholm8 Gothenburg5 Uppsala3 Lund3 Solna2
All 8 locations
Target enrolment
to

Non-Small Cell Lung Cancer trials in Sweden

13 of 2213 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Active, closed
BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors
NCT06205706Solid Tumors, Non Small Cell Lung Cancer, Hepatocellular Carcinoma
BioInvent International AB
Phase 1/2
35
Lund, Stockholm
2023-12-04
Recruiting
Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease
NCT06141070Non Small Cell Lung Cancer
Vastra Gotaland Region
Phase 3
240
Gothenburg, Linkรถping, Lund, Stockholm, Umeรฅ, Uppsala
2023-12-01
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
NCT05899608Non-Small Cell Lung Cancer
Summit Therapeutics
Phase 3
1,600
Stockholm, Uppsala
2023-10-26
Recruiting
Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)
NCT05724004Radiotherapy Side Effect, Non-small Cell Lung Cancer, ALK Gene Mutation
Karolinska University Hospital
Not applicable
70
Stockholm
2023-10-05
Recruiting
EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study
NCT06486142Non-Small Cell Lung Cancer
Region Skane
Phase 3
200
Lund
2022-09-21
Active, closed
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
NCT04886804Neoplasm Metastasis, Non-Small Cell Lung Cancer
Boehringer Ingelheim
Phase 1
554
Stockholm
2021-07-02
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-sweden/condition/non-small-cell-lung-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,213 studies in total at the last sync on 26 Sep 2026, 19:46 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies listing the condition Non-Small Cell Lung Cancer.

How many Non-Small Cell Lung Cancer trials are recruiting in Sweden?

7 of the 13 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:46 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Non-Small Cell Lung Cancer), 13 studies
PhaseStudiesRecruitingShare
Phase 37553.8%
Phase 1/22115.4%
Phase 22015.4%
Not applicable117.7%
Phase 1107.7%

Most active sponsors

Lead sponsors with the most studies (Non-Small Cell Lung Cancer)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche31
AstraZeneca20
Boehringer Ingelheim21
AbbVie11
BioInvent International AB10
Karolinska University Hospital11
Region Skane11
Summit Therapeutics11
Vastra Gotaland Region11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.